ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Knowledge graph and emerging trends in β-arrestin research on pain: a bibliometric analysis (1997-2025).
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to systematically analyze the characteristics of research output, core research foci, and evolutionary trends concerning β-arrestin in the field of pain research from 1997 to 2025 using bibliometric methods. The goal was to clarify the developmental trajectory and identify priority research areas within this domain. This study retrieved literature pertaining to "β-arrestin," "opioid receptors," and "pain" from the Web of Science Core Collection database, Scopus, and PubMed, covering the period from January 1, 1997 to November 22, 2025. Following rigorous screening based on predefined inclusion/exclusion criteria, the eligible publications were systematically analyzed regarding publication trends, core authors and collaborative networks, institutional and national contributions, journal co-citation patterns, co-citation networks of highly influential literature, and keyword clustering with burst detection trends. The final analysis comprised 635 articles. Analysis revealed a steady increase in the number of publications over the period 1997-2025. The USA emerged as the most productive country and also demonstrated the highest scientific influence. The top four institutions by publication volume were University of California System, Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, State University System of Florida, and University of Florida. NATURE was identified as the most frequently cited journal. Keyword analysis indicated that "mu-opioid receptor" exhibited the strongest citation burst strength, while "biased agonism," "opioid receptors," and "G protein" emerged as recent high-frequency terms. The current research hotspots in the field of β-arrestin and pain include directions such as "TRV130 (oliceridine)" and "G protein biased ligand." The research frontier is primarily focused on three key aspects: (1) the pharmacological mechanisms of β-arrestin-mediated pain signaling, (2) the development of G protein-biased ligands, and (3) translational applications for clinical analgesia. Collectively, β-arrestin demonstrates significant potential within the pain research domain. However, core challenges remain: the signaling pathway differences of β-arrestin2 across various pain types are not yet fully elucidated; the "functional selectivity" of biased ligands is difficult to quantify precisely; and the association between the intensity of β-arrestin recruitment and adverse effects remains controversial. Future breakthroughs necessitate interdisciplinary collaboration to fully unlock the therapeutic potential of β-arrestin in pain management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.